A kinase-anchoring proteins and adenylyl cyclase in cardiovascular physiology and pathology

Journal of Cardiovascular Pharmacology

Volumn 58, Issue 4, 2011, Pages 339-344

  Efendiev, Riad ^a   Dessauer, Carmen W ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

A kinase anchoring protein; adenylyl cyclase; adrenergic receptor; G protein coupled receptor; phosphodiesterase; protein kinase A

Indexed keywords

A KINASE ANCHOR PROTEIN 150; A KINASE ANCHOR PROTEIN 5; A KINASE ANCHOR PROTEIN 79; ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN; CALCIUM CHANNEL L TYPE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; G PROTEIN COUPLED RECEPTOR; MEMBRANE PROTEIN; MUSCLE SPECIFIC A KINASE ANCHOR PROTEIN; POTASSIUM CHANNEL KCNQ1; RECEPTOR; RELAXIN FAMILY PEPTIDE RECEPTOR 1; SODIUM CALCIUM EXCHANGE PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; YOTIAO PROTEIN;

AMINO TERMINAL SEQUENCE; ANGINA PECTORIS; APOPTOSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CELL COMPARTMENTALIZATION; CONGESTIVE HEART FAILURE; ENZYME PHOSPHORYLATION; FIBROBLAST; GENE OVEREXPRESSION; HEART ARRHYTHMIA; HEART FAILURE; HEART HYPERTROPHY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HUMAN; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; SINUS NODE; WILD TYPE;

A KINASE ANCHOR PROTEINS; ACTION POTENTIALS; ADENYLATE CYCLASE; ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CYCLIC AMP; HUMANS; ISOENZYMES; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 80053951322     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31821bc3f0     Document Type: Review

References (73)

1. Sadana R, Dessauer CW. Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies. NeuroSignals. 2009;17:5-22.
2. Antos CL, Frey N, Marx SO, et al. Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase A. Circ Res. 2001;89:997-1004. (Pubitemid 34640866)
3. Fink MA, Zakhary DR, Mackey JA, et al. AKAP-mediated targeting of protein kinase a regulates contractility in cardiac myocytes. Circ Res. 2001;88:291-297. (Pubitemid 32173752)
4. Alig J, Marger L, Mesirca P, et al. Control of heart rate by cAMP sensitivity of HCN channels. Proc Natl Acad Sci U S A. 2009;106: 12189-12194.
5. MetrichM, Berthouze M, Morel E, et al. Role of the cAMP-binding protein Epac in cardiovascular physiology and pathophysiology. Pflugers Arch-Eur J Physiol. 2010;459:535-546.
6. Gao M, Ping P, Post S, et al. Increased expression of adenylylcyclase type VI proportionately increases beta-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A. 1998;95:1038-1043. (Pubitemid 28124908)
7. 2+ regulation of adenylyl cyclases in cAMP microdomains. Physiol Rev. 2007;87:965-1010. (Pubitemid 47084674)
8. 2+-stimulated adenylyl cyclase isoform AC1 is preferentially expressed in guinea-pig sino-atrial node cells and modulates the I(f) pacemaker current. J Physiol (Lond). 2007;582:1195-1203. (Pubitemid 47104348)
9. 2+/calmodulin. Gq-Gs cross-talk regulates collagen production in cardiac fibroblasts. J Biol Chem. 2003;278:24461-24468. (Pubitemid 37548597)
10. Iwatsubo K, Minamisawa S, Tsunematsu T, et al. Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deterioration. J Biol Chem. 2004;279:40938-40945. (Pubitemid 39287693)
11. Okumura S, Kawabe J, Yatani A, et al. Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calciummediated cardiac regulation. Circ Res. 2003;93:364-371. (Pubitemid 37048249)
12. Boivin B, Lavoie C, Vaniotis G, et al. Functional beta-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes. Cardiovasc Res. 2006;71:69-78. (Pubitemid 43849672)
13. Ping P, Anzai T, Gao M, et al. Adenylyl cyclase and G protein receptor kinase expression during development of heart failure. Am J Physiol Heart Circ Physiol. 1997;273:H707-H717.
14. Guellich A, Gao S, Hong C, et al. Effects of cardiac overexpression of type 6 adenylyl cyclase affects on the response to chronic pressure overload. Am J Physiol Heart Circ Physiol. 2010;299:H707-H712.
15. Takahashi T, Tang T, Lai NC, et al. Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction. Circulation. 2006;114:388-396. (Pubitemid 44264820)
16. Okumura S, Takagi G, Kawabe J, et al. Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. Proc Natl Acad Sci U S A. 2003;100:9986-9990. (Pubitemid 37087055)
17. Yan L, Vatner DE, O'Connor JP, et al. Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell. 2007;130:247-258. (Pubitemid 47081133)
18. Engelhardt S, Hein L, Wiesmann F, et al. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A. 1999;96:7059-7064. (Pubitemid 29275009)
19. Iwase M, Uechi M, Vatner DE, et al. Cardiomyopathy induced by cardiac Gs alpha overexpression. Am J Physiol Heart Circ Physiol. 1997;272:H585-H589.
20. Hu CL, Chandra R, Ge H, et al. Adenylyl cyclase type 5 protein expression during cardiac development and stress. Am J Physiol Heart Circ Physiol. 2009;297:H1776-H1782.
21. Gao MH, Tang T, Guo T, et al. Adenylyl cyclase type VI increases Akt activity and phospholamban phosphorylation in cardiac myocytes. J Biol Chem. 2008;283:33527-33535.
22. Sugano Y, Lai NC, Gao MH, et al. Activated expression of cardiac adenylyl cyclase 6 reduces dilation and dysfunction of the pressureoverloaded heart. Biochem Biophys Res Commun. 2011;405:349-355.
23. Tang T, Gao MH, Lai NC, et al. Adenylyl cyclase type 6 deletion decreases left ventricular function via impaired calcium handling. Circulation. 2008;117:61-69. (Pubitemid 350291182)
24. Tang T, Lai NC, Hammond HK, et al. Adenylyl cyclase 6 deletion reduces left ventricular hypertrophy, dilation, dysfunction, and fibrosis in pressureoverloaded female mice. J Am Coll Cardiol. 2010;55:1476-1486.
25. Das M, Das DK. Lipid raft in cardiac health and disease. Curr Cardiol Rev. 2009;5:105-111.
26. Insel PA, Patel HH. Membrane rafts and caveolae in cardiovascular signaling. Curr Opin Nephrol Hypertens. 2009;18:50-56.
27. Ostrom RS, Liu X, Head BP, et al. Localization of adenylyl cyclase isoforms and G protein-coupled receptors in vascular smooth muscle cells: expression in caveolin-rich and noncaveolin domains. Mol Pharmacol. 2002;62:983.
28. Patel HH, Tsutsumi YM, Head BP, et al. Mechanisms of cardiac protection from ischemia/reperfusion injury: a role for caveolae and caveolin-1. FASEB J. 2007;21:1565-1574. (Pubitemid 46684858)
29. Das M, Gherghiceanu M, Lekli I, et al. Essential role of lipid raft in ischemic preconditioning. Cell Physiol Biochem. 2008;21:325-334. (Pubitemid 351591424)
30. 2+ entry. J Biol Chem. 2000;275:40187-40194. (Pubitemid 32064648)
31. 2+-regulated adenylyl cyclases from changes in intracellular pH. J Biol Chem. 2005;280:30864-30872. (Pubitemid 41291817)
32. Yu HJ, Ma H, Green RD. Calcium entry via L-type calcium channels acts as a negative regulator of adenylyl cyclase activity and cyclic AMP levels in cardiac myocytes. Mol Pharmacol. 1993;44:689.
33. Dodge-Kafka KL, Langeberg L, Scott JD. Compartmentation of cyclic nucleotide signaling in the heart-the role of A-kinase anchoring proteins. Circ Res. 2006;98:993-1001.
34. Logue JS, Scott JD. Organizing signal transduction through A-kinase anchoring proteins (AKAPs). FEBS J. 2010;277:4370-4375.
35. Scott JD, Santana LF. A-kinase anchoring proteins: getting to the heart of the matter. Circulation. 2010;121:1264-1271.
36. Mauban JR, O'Donnell M, Warrier S, et al. AKAP-scaffolding proteins and regulation of cardiac physiology. Physiology (Bethesda). 2009;24:78-87.
37. Kockskamper J, Sendhoff K, Erlenkamp S, et al. Differences in the proteinkinase- A-dependent regulation of CFTR Cl- channels and Na+-K+ pumps in guinea-pig ventricular myocytes. Pflugers Arch. 2001;441:807-815. (Pubitemid 32186548)
38. 2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron. 1997;19:185-196. (Pubitemid 27333004)
39. McConnell BK, Popovic Z, Mal N, et al. Disruption of protein kinase A interaction with A-kinase-anchoring proteins in the heart in vivo: effects on cardiac contractility, protein kinase A phosphorylation, and troponin I proteolysis. J Biol Chem. 2009;284:1583-1592.
40. Dessauer CW. Adenylyl cyclase-A-kinase anchoring protein complexes: the next dimension in cAMP signaling. Mol Pharmacol. 2009;76:935-941.
41. Bauman AL, Soughayer J, Nguyen BT, et al. Dynamic regulation of cAMP synthesis through anchored PKA-adenylyl cyclase V/VI complexes. Mol Cell. 2006;23:925-931. (Pubitemid 44363046)
42. Efendiev R, Samelson BK, Nguyen BT, et al. AKAP79 interacts with multiple adenylyl cyclase (AC) isoforms and scaffolds AC5 and -6 to alpha-amino-3- hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptors. J Biol Chem. 2010;285:14450-14458.
43. Nichols CB, Rossow CF, Navedo MF, et al. Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels. Circ Res. 2010;107:747-756.
44. 2+ sparklets and angiotensin II-induced hypertension. Circ Res. 2008;102:e1-e11. (Pubitemid 351651131)
45. 2+ channels during hypertension and Timothy syndrome. Circ Res. 2010; 106:748-756.
46. Halls ML, Cooper DM. Sub-picomolar relaxin signalling by a preassembled RXFP1, AKAP79, AC2, beta-arrestin 2, PDE4D3 complex. EMBO J. 2010;29:2772-2787.
47. Lin JW, Wyszynski M, Madhavan R, et al. Yotiao, a novel protein of neuromuscular junction and brain that interacts with specific splice variants of NMDA receptor subunit NR1. J Neurosci. 1998;18:2017-2027. (Pubitemid 28141409)
48. Westphal RS, Tavalin SJ, Lin JW, et al. Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex. Science. 1999;285:93-96. (Pubitemid 29307572)
49. Terrenoire C, Houslay MD, Baillie GS, et al. The cardiac IKs potassium channel macromolecular complex includes the phosphodiesterase PDE4D3. J Biol Chem. 2009;284:9140-9146.
50. Marx SO, Kurokawa J, Reiken S, et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science. 2002;295:496-499. (Pubitemid 34101639)
51. Chen L, Marquardt ML, Tester DJ, et al. Mutation of an A-kinaseanchoring protein causes long-QT syndrome. Proc Natl Acad Sci U S A. 2007;104:20990-20995.
52. Piggott LA, Bauman AL, Scott JD, et al. The A-kinase anchoring protein Yotiao binds and regulates adenylyl cyclase in brain. Proc Natl Acad Sci U S A. 2008;105:13835-13840.
53. Kapiloff MS, Schillace RV, Westphal AM, et al. mAKAP: an A-kinase anchoring protein targeted to the nuclear membrane of differentiated myocytes. J Cell Sci. 1999;112:2725-2736. (Pubitemid 29429795)
54. Pare GC, Easlick JL, Mislow JM, et al. Nesprin-1alpha contributes to the targeting of mAKAP to the cardiac myocyte nuclear envelope. Exp Cell Res. 2005;303:388-399. (Pubitemid 40126271)
55. Ruehr ML, Russell MA, Ferguson DG, et al. Targeting of protein kinase A by muscle a kinase-anchoring protein (mAKAP) regulates phosphorylation and function of the skeletal muscle ryanodine receptor. J Biol Chem. 2003;278:24831-24836. (Pubitemid 37548641)
56. Kapiloff MS, Piggott LA, Sadana R, et al. An adenylyl cyclasemAKAPbeta signaling complex regulates cAMP levels in cardiac myocytes. J Biol Chem. 2009;284:23540-23546.
57. Gao T, Puri TS, Gerhardstein BL, et al. Identification and subcellular localization of the subunits of L-type calcium channels and adenylyl cyclase in cardiac myocytes. J Biol Chem. 1997;272:19401-19407. (Pubitemid 27337736)
58. Escobar M, Cardenas C, Colavita K, et al. Structural evidence for perinuclear calcium microdomains in cardiac myocytes. J Mol Cell Cardiol. 2011;50:451-459.
59. Dodge-Kafka KL, Bauman A, Mayer N, et al. cAMP-stimulated protein phosphatase 2A activity associated with muscle A kinase-anchoring protein (mAKAP) signaling complexes inhibits the phosphorylation and activity of the cAMP-specific phosphodiesterase PDE4D3. J Biol Chem. 2010;285:11078-11086.
60. Wong W, Goehring AS, Kapiloff MS, et al. mAKAP compartmentalizes oxygen-dependent control of HIF-1alpha. Sci Signal. 2008;1:ra18.
61. Dodge KL, Khouangsathiene S, Kapiloff MS, et al. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J. 2001;20:1921-1930. (Pubitemid 32397394)
62. Dodge-Kafka KL, Soughayer J, Pare GC, et al. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature. 2005;437:574-578. (Pubitemid 41613557)
63. Kapiloff MS, Jackson N, Airhart N. mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardiomyocyte nuclear envelope. J Cell Sci. 2001;114:3167-3176. (Pubitemid 32910471)
64. Michel JJ, Townley IK, Dodge-Kafka KL, et al. Spatial restriction of PDK1 activation cascades by anchoring to mAKAPalpha. Mol Cell. 2005; 20:661-672. (Pubitemid 41740689)
65. Michel JJC, Dodge KL, Wong W, et al. PKAphosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex. Biochem J. 2004;381:587-592. (Pubitemid 39120466)
66. Pare GC, Bauman AL, McHenry M, et al. The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling. J Cell Sci. 2005;118:5637-5646. (Pubitemid 43079302)
67. Marx SO, Reiken S, Hisamatsu Y, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 2000;101:365-376.
68. Schulze DH, Muqhal M, Lederer WJ, et al. Sodium/calcium exchanger (NCX1) macromolecular complex. J Biol Chem. 2003;278: 28849-28855. (Pubitemid 36935795)
69. Fraser ID, Tavalin SJ, Lester LB, et al. A novel lipid-anchored A-kinase anchoring protein facilitates cAMP-responsive membrane events. EMBO J. 1998;17:2261-2272. (Pubitemid 28171911)
70. Gray PC, Johnson BD, Westenbroek RE, et al. Primary structure and function of an A kinase anchoring protein associated with calcium channels. Neuron. 1998;20:1017-1026. (Pubitemid 28247406)
71. Lygren B, Carlson CR, Santamaria K, et al. AKAP complex regulates Ca(2+) re-uptake into heart sarcoplasmic reticulum. EMBO Rep. 2007;8: 1061-1067. (Pubitemid 350042342)
72. Hulme JT, Lin TW, Westenbroek RE, et al. Beta-adrenergic regulation requires direct anchoring of PKA to cardiac CaV1.2 channels via a leucine zipper interaction with A kinase-anchoring protein 15. Proc Natl Acad Sci U S A. 2003;100:13093-13098. (Pubitemid 37340031)
73. Hulme JT,Westenbroek RE, Scheuer T, et al. Phosphorylation of serine 1928 in the distal C-terminal domain of cardiac CaV1.2 channels during beta1- adrenergic regulation. Proc Natl Acad Sci U S A. 2006;103:16574-16579. (Pubitemid 44715237)